Home > Financial Ratios > PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH
Core EBITDA Growth

    Back to All Ratios
PROCTER & GAMBLE HEALTH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for PROCTER & GAMBLE HEALTH
Please provide your vote to see the results

PROCTER & GAMBLE HEALTH Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Jun2024Mar2024Jun2023Jun2022
   Core EBITDA Growth(%) 2.21-6.25-6.2522.156.34

What is the latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH ?

The latest Core EBITDA Growth ratio of PROCTER & GAMBLE HEALTH is 2.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20252.21
Jun2024-6.25
Mar2024-6.25
Jun202322.15
Jun20226.34

How is Core EBITDA Growth of PROCTER & GAMBLE HEALTH Trending?

Years Core EBITDA Growth % Change
Mar2025 2.21
Positive
Jun2024 -6.25
Negative
Mar2024 -6.25
Negative
Jun2023 22.15
249.37
Jun2022 6.34 -

Other Financial Ratios of PROCTER & GAMBLE HEALTH


Compare Core EBITDA Growth ratio of peers of PROCTER & GAMBLE HEALTH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH ₹10,511.0 Cr -2% -0% 23.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹382,370.0 Cr 0.7% 0.4% -12.5% Stock Analytics
DIVIS LABORATORIES ₹160,087.0 Cr -1.7% 2% 16.7% Stock Analytics
CIPLA ₹126,308.0 Cr -0.9% 5.3% -3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹121,614.0 Cr -0.1% 0.6% 6.6% Stock Analytics
DR REDDYS LABORATORIES ₹108,845.0 Cr 4.1% 7.6% -3% Stock Analytics


PROCTER & GAMBLE HEALTH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PROCTER & GAMBLE HEALTH

-2%

-0%

23.1%

SENSEX

1.1%

1%

-0.9%


You may also like the below Video Courses